4.5 Article

Multi-Resistant Aspergillosis due to Cryptic Species

Journal

MYCOPATHOLOGIA
Volume 178, Issue 5-6, Pages 435-439

Publisher

SPRINGER
DOI: 10.1007/s11046-014-9774-0

Keywords

Aspergillus; Susceptibility; Resistance; Sibling; Cryptic; Antifungal

Categories

Funding

  1. Astellas
  2. Gilead
  3. Pfizer
  4. Fungal Research Trust
  5. Schering-Plough

Ask authors/readers for more resources

Reports of cryptic species causing aspergillosis in humans are increasing in the literature. Cryptic species are defined as those which are morphologically indistinguishable, although their identifications can be confirmed using molecular or other techniques which continue to become more widely available in the clinical setting. Antifungal resistance has often been noted in these cases, and indeed there does appear to be a higher prevalence of reduced susceptibility in cryptic species. Many of these observations are published as individual case reports or as a small component of larger data sets, making it challenging to review and compare the data fully. This review article seeks to describe the susceptibility trends and key learning outcomes of specific cases of infections caused by cryptic species, including Aspergillus alliaceus, Aspergillus calidoustus, Aspergillus felis, Aspergillus lentulus, Aspergillus tubingensis, Aspergillus viridinutans and Neosartorya pseudofischeri. These reports highlight the clinical need for full accurate identification and susceptibility testing to guide patient care.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available